Transplant International 1993-01-01

Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution.

J Jacobsson, R Sundberg, H L Rilo, A Gasbarrini, T E Starzl, D Van Thiel

Index: Transpl. Int. 6(5) , 281-4, (1993)

Full Text: HTML

Abstract

The effect of adding a 21-aminosteroid, U74500A, and a Ca2+ antagonist, lidoflazine, alone and together to UW solution was assessed in a rat liver preservation model. Following preservation, the livers were reperfused using a closed circuit, and the release of hepatocellular enzymes (ASAT, ALAT, and LDH) into the perfusate was determined with increasing time. Both drugs reduced the amount of enzymes lost from the liver. The combination of the two drugs was better than either drug alone. These data suggest that both agents may be of value in organ preservation for clinical liver transplantation.

Related Compounds

  • Lidoflazine

Related Articles:

Simpson's paradox and clinical trials: what you find is not necessarily what you prove.

1992-12-01

[Ann. Emerg. Med. 21(12) , 1480-2, (1992)]

1,4-Dihydropyridines bearing a pharmacophoric fragment of lidoflazine.

1996-10-01

[Bioorg. Med. Chem. 4(10) , 1629-35, (1996)]

Effects of lidoflazine on left ventricular function in patients.

1997-02-01

[J. Cardiothorac. Vasc. Anesth. 11(1) , 42-8, (1997)]

The pathophysiology of angina pectoris and the effect of lidoflazine.

1982-01-01

[Circulation 65(1 Pt 2) , I27-32, (1982)]

Lidoflazine and myocardial protection.

1995-05-01

[J. Thorac. Cardiovasc. Surg. 109(5) , 1013-4; discussion 1015, (1995)]

More Articles...